Guannan Mu

No. 150, Haping Road
Harbin, 150040, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 8 publications

MicroRNA-375 promotes tamoxifen resistance by stabilizing ERα via UBE3A-mediated ubiquitination.

MicroRNA-375 promotes tamoxifen resistance by stabilizing ERα via UBE3A-mediated ubiquitination.

Journal: International immunopharmacology

Published: November 11, 2025

Global perspectives on the contribution of B cells to multiple sclerosis: an in-depth examination and evaluation.

Global perspectives on the contribution of B cells to multiple sclerosis: an in-depth examination and evaluation.

Journal: Frontiers in immunology

Published: June 02, 2024

MicroRNA-375 restrains the progression of lung squamous cell carcinoma by modulating the ERK pathway via UBE3A-mediated DUSP1 degradation.

MicroRNA-375 restrains the progression of lung squamous cell carcinoma by modulating the ERK pathway via UBE3A-mediated DUSP1 degradation.

Journal: Cell death discovery

Published: December 24, 2022

MicroRNA-375 is a therapeutic target for castration-resistant prostate cancer through the PTPN4/STAT3 axis.

MicroRNA-375 is a therapeutic target for castration-resistant prostate cancer through the PTPN4/STAT3 axis.

Journal: Experimental & molecular medicine

Published: February 19, 2022

Arsenic trioxide decreases the amount and inhibits the function of regulatory T cells, which may contribute to its efficacy in the treatment of acute promyelocytic leukemia.

Arsenic trioxide decreases the amount and inhibits the function of regulatory T cells, which may contribute to its efficacy in the treatment of acute promyelocytic leukemia.

Journal: Leukemia & lymphoma

Published: July 07, 2017

Influence of the number and interval of treatment cycles on cytokine-induced killer cells and their adjuvant therapeutic effects in advanced non-small-cell lung cancer (NSCLC).

Influence of the number and interval of treatment cycles on cytokine-induced killer cells and their adjuvant therapeutic effects in advanced non-small-cell lung cancer (NSCLC).

Journal: International immunopharmacology

Published: May 04, 2017

CPA-7 influences immune profile and elicits anti-prostate cancer effects by inhibiting activated STAT3.

CPA-7 influences immune profile and elicits anti-prostate cancer effects by inhibiting activated STAT3.

Journal: BMC cancer

Published: February 24, 2016

The long non-coding RNA EPB41L4A-AS2 inhibits tumor proliferation and is associated with favorable prognoses in breast cancer and other solid tumors.

The long non-coding RNA EPB41L4A-AS2 inhibits tumor proliferation and is associated with favorable prognoses in breast cancer and other solid tumors.

Journal: Oncotarget

Published: November 12, 2015

Showing 1-8 of 8

Last Updated: 09/26/2026